In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI. (Q40984161)

25 September 2017

In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI. (English)

1 reference

25 September 2017

Xu ZQ

1

1 reference

25 September 2017

Buckheit RW Jr

2

1 reference

25 September 2017

Stup TL

3

1 reference

25 September 2017

Flavin MT

4

1 reference

25 September 2017

Khilevich A

5

1 reference

25 September 2017

Rizzo JD

6

1 reference

25 September 2017

Lin L

7

1 reference

25 September 2017

Zembower DE

8

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

25 September 2017

6

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

25 September 2017

8

1 reference

25 September 2017

16

1 reference

25 September 2017

2179-2184

1 reference

The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900380-1

7 January 2021

The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900380-1

7 January 2021

Synthesis, chromatographic resolution, and anti-human immunodeficiency virus activity of (+/-)-calanolide A and its enantiomers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900380-1

7 January 2021

Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900380-1

7 January 2021

Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900380-1

7 January 2021

Comparative anti-HIV evaluation of diverse HIV-1-specific reverse transcriptase inhibitor-resistant virus isolates demonstrates the existence of distinct phenotypic subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900380-1

7 January 2021

Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900380-1

7 January 2021

Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900380-1

7 January 2021

Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type-1-specific compounds related to oxathiin carboxanilide

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900380-1

7 January 2021

Structural analogues of the calanolide anti-HIV agents. Modification of the trans-10,11-dimethyldihydropyran-12-ol ring (ring C).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900380-1

7 January 2021

Structure-activity modifications of the HIV-1 inhibitors (+)-calanolide A and (-)-calanolide B.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900380-1

7 January 2021

Differential inhibitory effects of TIBO derivatives on different strains of simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900380-1

7 January 2021

10.1016/S0960-894X(98)00380-1

Identifiers

DOI

1 reference

25 September 2017

1 reference